<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<rss version="2.0">
  <channel>
    <title>Clinical Chemistry and Laboratory Medicine (CCLM)</title>
    <link>www.degruyter.com</link>
    <description/>
    <item>
      <title>Frontmatter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-frontmatter8/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-frontmatter8/html</guid>
    </item>
    <item>
      <title>Analytical performance specifications – moving from models to practical recommendations</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0661/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0661/html</guid>
    </item>
    <item>
      <title>What the Milan conference has taught us about analytical performance specification model definition and measurand allocation</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1257/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1257/html</guid>
    </item>
    <item>
      <title>The role of analytical performance specifications in international guidelines and standards dealing with metrological traceability in laboratory medicine</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1201/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1201/html</guid>
    </item>
    <item>
      <title>How clinical laboratories select and use Analytical Performance Specifications (APS) in Italy</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1314/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1314/html</guid>
    </item>
    <item>
      <title>Outcome-based analytical performance specifications: current status and future challenges</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0125/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0125/html</guid>
    </item>
    <item>
      <title>Analytical performance specifications based on biological variation data – considerations, strengths and limitations</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0108/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0108/html</guid>
    </item>
    <item>
      <title>State-of-the-art model for derivation of analytical performance specifications: how to define the highest level of analytical performance technically achievable</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1286/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1286/html</guid>
    </item>
    <item>
      <title>Analytical performance specifications for combined uncertainty budget in the implementation of metrological traceability</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1325/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1325/html</guid>
    </item>
    <item>
      <title>When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1303/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1303/html</guid>
    </item>
    <item>
      <title>Using analytical performance specifications in a medical laboratory</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0102/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0102/html</guid>
    </item>
    <item>
      <title>Issues in assessing analytical performance specifications in healthcare systems assembling multiple laboratories and measuring systems</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1208/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1208/html</guid>
    </item>
    <item>
      <title>Applying the Milan models to setting analytical performance specifications – considering all the information</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0104/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0104/html</guid>
    </item>
    <item>
      <title>Recommendations for blood sampling in emergency departments from the European Society for Emergency Medicine (EUSEM), European Society for Emergency Nursing (EuSEN), and European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase. Executive summary</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0059/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0059/html</guid>
    </item>
    <item>
      <title>Assessment of accuracy of laboratory testing results, relative to peer group consensus values in external quality control, by bivariate z-score analysis: the example of D-Dimer</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0835/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0835/html</guid>
    </item>
    <item>
      <title>The stability of 65 biochemistry analytes in plasma, serum, and whole blood</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1192/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1192/html</guid>
    </item>
    <item>
      <title>Assessment of the 2023 European Kidney Function Consortium (EKFC) equations in a Chinese adult population</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0080/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0080/html</guid>
    </item>
    <item>
      <title>In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1360/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1360/html</guid>
    </item>
    <item>
      <title>Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1256/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1256/html</guid>
    </item>
    <item>
      <title>Association of prehospital lactate levels with base excess in various emergencies – a retrospective study</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0060/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0060/html</guid>
    </item>
    <item>
      <title>Stability of ten serum tumor markers after one year of storage at −18°C</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1312/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1312/html</guid>
    </item>
    <item>
      <title>Variations in tumor growth, intra-individual biological variability, and the interpretation of changes</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0780/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0780/html</guid>
    </item>
    <item>
      <title>N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1189/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1189/html</guid>
    </item>
    <item>
      <title>Reference intervals for high sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide in children and adolescents on the Siemens Atellica</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0977/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0977/html</guid>
    </item>
    <item>
      <title>Fetal chronic hypoxia does not affect urinary presepsin levels in newborns at birth</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1308/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1308/html</guid>
    </item>
    <item>
      <title>AWMF statement on medical services in laboratory diagnostics and pathology with regard to the IVDR</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0254/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0254/html</guid>
    </item>
    <item>
      <title>An outline of measurement uncertainty of total protein in urine estimated according to the ISO Technical Specification 20914</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0064/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0064/html</guid>
    </item>
    <item>
      <title>Early diagnosis of severe illness in an outpatient – the Sysmex XN’s neutrophil reactivity parameter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1406/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1406/html</guid>
    </item>
    <item>
      <title>Analytical and diagnostic performance of Theradiag i-Tracker assays on IDS-iSYS for infliximab and adalimumab therapeutic drug monitoring</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1432/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1432/html</guid>
    </item>
    <item>
      <title>Improving the diagnosis of AATD with aid of serum protein electrophoresis: a prospective, multicentre, validation study</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0176/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2024-0176/html</guid>
    </item>
    <item>
      <title>Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1416/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1416/html</guid>
    </item>
    <item>
      <title>Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1490/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-1490/html</guid>
    </item>
  </channel>
</rss>
